Moore Matthew Richard
- SEC CIK
- 0001840191
No open-market purchases or sales filed in the past year.
Current role at each company
- VTYX Ventyx Biosciences, Inc.Chief Operating Officeras of Mar 4, 2026
- ARQT Arcutis Biotherapeutics, Inc.SVP and Chief Business Officeras of May 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Moore Matthew Richard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARQT Arcutis Biotherapeutics, Inc.
SVP and Chief Business Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2024 (view filing) | May 2 | 1 day | Moore Matthew RichardSVP and Chief Business Officer | SSale | −4.68K | $8.74 | −$40.9K | −3.1%145.5K after | 10b5-1 |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Moore Matthew RichardSVP and Chief Business Officer | SSale | −3.47K | $11.12 | −$38.6K | −2.3%146.0K after | 10b5-1 |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Moore Matthew RichardSee Remarks | SSale | −1.61K | $15.83 | −$25.5K | −12.1%11.7K after | 2 lots |